Wall Street expects a year-over-year decline in earnings on lower revenues when Icon PLC (ICLR) reports results for the quarter ended March 2025. While this widely-known consensus outlook is ...

DUBLIN, March 31, 2025--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its ...

Icon Plc and Medpace are both CROs, but Icon focuses on large pharma with an aggressive M&A strategy, unlike Medpace's small biotech focus. Initially impressed by Icon's financials, we purchased ...

Cruz announces that investors with losses related to ICON plc ("ICON" or the "Company") (NASDAQ: ICLR) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR ...

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us. Charles ...

LOS ANGELES, April 10, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against ICON plc ...

Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against ICON plc ("ICON" or the "Company") (NASDAQ: ICLR ). IF YOU ARE AN ...

Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at info@rgrdlaw.com. CASE ALLEGATIONS: ICON is a clinical research organization ("CRO"). The ICON class action lawsuit alleges that ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In ICON To Contact Him Directly To Discuss Their Options If you ...